|
|
Rockwell Medical Technologies to Present At the 2009 JMP ... - GlobeNewsWire (press release) |
|
GlobeNewsWire (press release)SFP is designed as a continuous maintenance treatment delivering small doses of iron during every dialysis session in order to offset iron losses during the ... |
|
|
Kidneys from deceased donors with acute renal failure expand donor ... - EurekAlert (press release) |
|
EurekAlert (press release)WINSTON-SALEM, NC – Kidneys recovered from deceased donors with acute renal failure (ARF) – once deemed unusable for transplant – appear to work just as ... |
|
Glaxo Kidney Cancer Drug Has Liver Risk, FDA Says - Bloomberg |
|
BloombergGlaxo's pazopanib may be “associated with a significant risk” of severe liver injury in patients with advanced renal cell carcinoma, the most-common form of ...FDA Staff Express Safety Concerns About GlaxoSmithKline's Votrient For Kidney ... |
|
US FDA staff questions Glaxo kidney cancer drug - Reuters |
|
ReutersVotrient, also known by its chemical name pazopanib, aims to treat advanced renal cell carcinoma. But while the company's data showed a 5-month improvement ... |
|
Astellas and Theravance Announce Approval of VIBATIV TM ... - Market Wire (press release) |
|
Market Wire (press release)New onset or worsening renal impairment occurred in patients who received VIBATIV. Renal adverse events were more likely to occur in patients with baseline ...Astellas and Theravance Announce Approval of VIBATIV(TM) in Canada ... |
|
|
|
|
<< Start < Prev 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 Next > End >>
|
|
Page 1995 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
